Mega Lifesciences PCL Stocks 2024

Mega Lifesciences PCL Stocks

871.87 M

Mega Lifesciences PCL Dividend yield

4.05 %

Ticker

MEGA.BK

ISIN

TH4984010009

In 2024, Mega Lifesciences PCL had 871.87 M outstanding stocks, a 0% change from the 871.87 M stocks in the previous year.

The Mega Lifesciences PCL Stocks history

YEARNUMBER OF STOCKS (undefined THB)
2026e871.87
2025e871.87
2024e871.87
2023871.87
2022871.87
2021871.87
2020871.87
2019870.85
2018869.04
2017868.24
2016865.25
2015865.25
2014865
2013747
2012728
2011728
2010728
20097

Mega Lifesciences PCL Aktienanalyse

What does Mega Lifesciences PCL do?

Mega Lifesciences PCL is a global healthcare company focused on innovative solutions and products for improving the health and well-being of people. It was founded in 1984 and is based in Bangkok, Thailand. The company operates in over 30 countries worldwide and employs over 5,000 employees. It started as a distribution-focused company but soon began developing its own products, starting with a dietary supplement called Bio-C Plus. Mega Lifesciences has grown through acquisitions and expanded its product portfolio. Its business model focuses on nutrition, health, and wellness, with a strong presence in Asia, Africa, Europe, and Latin America. The company is divided into different divisions including healthcare products, dietary supplements, veterinary medicine, and licensed products. Some of its products include Megaheart for cardiovascular diseases, Megamycin as an antibiotic, Megavit as a dietary supplement, Megaderm for skin diseases in animals, and licensed products from international pharmaceutical and healthcare companies. Mega Lifesciences aims to improve people's lives and promote their health through its diverse range of products. Mega Lifesciences PCL ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Mega Lifesciences PCL's Shares Outstanding

Mega Lifesciences PCL's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Mega Lifesciences PCL’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Mega Lifesciences PCL’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Mega Lifesciences PCL’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Mega Lifesciences PCL Stock

How many stocks are there of Mega Lifesciences PCL?

The current number of stocks of Mega Lifesciences PCL is 871.87 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Mega Lifesciences PCL are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Mega Lifesciences PCL evolved in recent years?

The number of shares of Mega Lifesciences PCL has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Mega Lifesciences PCL as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Mega Lifesciences PCL?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Mega Lifesciences PCL pay?

Over the past 12 months, Mega Lifesciences PCL paid a dividend of 1.65 THB . This corresponds to a dividend yield of about 4.05 %. For the coming 12 months, Mega Lifesciences PCL is expected to pay a dividend of 1.91 THB.

What is the dividend yield of Mega Lifesciences PCL?

The current dividend yield of Mega Lifesciences PCL is 4.05 %.

When does Mega Lifesciences PCL pay dividends?

Mega Lifesciences PCL pays a quarterly dividend. This is distributed in the months of September, April, September, April.

How secure is the dividend of Mega Lifesciences PCL?

Mega Lifesciences PCL paid dividends every year for the past 13 years.

What is the dividend of Mega Lifesciences PCL?

For the upcoming 12 months, dividends amounting to 1.91 THB are expected. This corresponds to a dividend yield of 4.68 %.

In which sector is Mega Lifesciences PCL located?

Mega Lifesciences PCL is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mega Lifesciences PCL kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mega Lifesciences PCL from 4/22/2024 amounting to 0.8 THB, you needed to have the stock in your portfolio before the ex-date on 3/6/2024.

When did Mega Lifesciences PCL pay the last dividend?

The last dividend was paid out on 4/22/2024.

What was the dividend of Mega Lifesciences PCL in the year 2023?

In the year 2023, Mega Lifesciences PCL distributed 1.16 THB as dividends.

In which currency does Mega Lifesciences PCL pay out the dividend?

The dividends of Mega Lifesciences PCL are distributed in THB.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Mega Lifesciences PCL

Our stock analysis for Mega Lifesciences PCL Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mega Lifesciences PCL Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.